Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Empagliflozin (Jardiance) and glimepiride (Amaryl) are both medications used to treat Type 2 diabetes, but they belong to different drug classes. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, while glimepiride is a sulfonylurea. Empagliflozin is also FDA-approved to lower the risk of heart and kidney problems in certain adults, whereas glimepiride is only approved for Type 2 diabetes. You take empagliflozin once daily in the morning, and glimepiride is taken once daily with your first main meal. Empagliflozin does not have a generic version available, but glimepiride is available as a lower-cost generic. Common side effects of empagliflozin include urinary tract infections, yeast infections, and frequent urination. Glimepiride can cause low blood sugar and weight gain as common side effects. Both medications can interact with alcohol and diabetes medications—leading to a higher risk of low blood sugar.
Glimepiride (Amaryl) is a medication used to treat type 2 diabetes along with healthy diet and exercise. It's part of the medication class called sulfonylureas. This medication is taken by mouth, typically once daily with the first main meal. Some common side effects of glimepiride (Amaryl) include headaches and low blood sugar. Like other medications in its class, it can also cause weight gain. Glimepiride (Amaryl) is available as both a brand name (Amaryl) and generic tablet.
Indications of Jardiance vs. Glimepiride
Indications for
•Type 2 diabetes (in addition to diet and exercise) in people age 10 years and older
•Lowering the risk of death due to heart problems in adults with Type 2 diabetes and heart disease
•Lowering the risk of hospitalization and death due to heart problems in adults with heart failure
•Lowering the risk of worsening kidney problems, hospitalization, and death due to heart problems in adults with chronic kidney disease (CKD)